Mesothelioma shows promising response to existing immunotherapy drug

Latest Posts

Targeted Radiation Wins for Treating ‘Numerous’ Brain Metastases

By Lizzy

Stereotactic radiosurgery (SRS) for cancer patients with four to 15 brain metastases staved off cognitive decline better than conventional whole-brain radiation therapy (WBRT), while yielding...

Comments closed

Updated Guidance OKs Sports Sooner After COVID-19

By Lizzy

Updated testing guidance from a group of sports cardiologists for return to practice and competition after COVID-19 remained fairly conservative. One of the notable changes...

Comments closed

Drive-Thru Clinic Viable for Routine Cardiac Device Checks

By Lizzy

Patients with cardiac implantable devices could undergo routine pacing checks successfully at a drive-through clinic, one group learned during the COVID-19 pandemic. A hospital set...

Comments closed

WHO says Covid vaccine trials are ‘encouraging’ but it’ll take time to ensure it’s safe for everyone

By Sheela

Laboratory technicians handle capped vials as part of filling and packaging tests for the large-scale production and supply of the University of Oxford's Covid-19 vaccine...

Comments closed

Sanofi, GSK to provide 200 million Covid vaccine doses to WHO global immunization program

By Sheela

A health worker wearing a protective mask works in a lab during clinical trials for a Covid-19 vaccine at Research Centers of America in Hollywood,...

Comments closed

Malignant pleural mesothelioma shows a promising response to treatment with the antibody drug pembrolizumab, which is used to treat other cancers.

Source: MedicalNewsToday.com